Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elazer R Edelman

Showing results (21-30 of 332) with videos related to

Pageof 34
Sort By:
Current Opinion in Pharmacology|February 14, 2012
Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitusDoron Aronson, Elazer R Edelman
Circulation|June 14, 2006
Cardiology is flowYoram Richter, Elazer R Edelman
Circulation Research|May 31, 2003
Tissue engineering therapy for cardiovascular diseaseHelen M Nugent, Elazer R Edelman
Science Translational Medicine|October 15, 2011
A rattle bag of science and the art of translationElazer R Edelman, Garret A FitzGerald
Circulation|July 9, 2003
Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds?Elazer R Edelman, Haim D Danenberg
Journal of Hepatology|May 30, 2015
Monocyte-endothelial cell interactions in the regulation of vascular sprouting and liver regeneration in mousePedro Melgar-Lesmes, Elazer R Edelman
Frontiers in Immunology|August 25, 2022
Substratum interactions determine immune response to allogeneic transplants of endothelial cellsElise C Wilcox, Elazer R Edelman
Journal of Theoretical Biology|January 18, 2005
On the validity of the quasi-steady state approximation of bimolecular reactions in solutionA Rami Tzafriri, Elazer R Edelman
Circulation. Cardiovascular Interventions|November 18, 2017
Needles in Our Technology Haystacks: Defining Efficacy Is Easy, Characterizing Complications Is the ChallengeElazer R Edelman, Pei-Jiang Wang
Cytotechnology|July 30, 2009
Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate bindingAlisa Morss Clyne, Elazer R Edelman
Pageof 34

Showing results (21-30 of 332) with videos related to

Sort By:
Pageof 34
Current Opinion in Pharmacology|February 14, 2012
Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitusDoron Aronson, Elazer R Edelman
Circulation|June 14, 2006
Cardiology is flowYoram Richter, Elazer R Edelman
Circulation Research|May 31, 2003
Tissue engineering therapy for cardiovascular diseaseHelen M Nugent, Elazer R Edelman
Science Translational Medicine|October 15, 2011
A rattle bag of science and the art of translationElazer R Edelman, Garret A FitzGerald
Circulation|July 9, 2003
Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds?Elazer R Edelman, Haim D Danenberg
Journal of Hepatology|May 30, 2015
Monocyte-endothelial cell interactions in the regulation of vascular sprouting and liver regeneration in mousePedro Melgar-Lesmes, Elazer R Edelman
Frontiers in Immunology|August 25, 2022
Substratum interactions determine immune response to allogeneic transplants of endothelial cellsElise C Wilcox, Elazer R Edelman
Journal of Theoretical Biology|January 18, 2005
On the validity of the quasi-steady state approximation of bimolecular reactions in solutionA Rami Tzafriri, Elazer R Edelman
Circulation. Cardiovascular Interventions|November 18, 2017
Needles in Our Technology Haystacks: Defining Efficacy Is Easy, Characterizing Complications Is the ChallengeElazer R Edelman, Pei-Jiang Wang
Cytotechnology|July 30, 2009
Vascular growth factor binding kinetics to the endothelial cell basement membrane, with a kinetics-based correction for substrate bindingAlisa Morss Clyne, Elazer R Edelman
Pageof 34